A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a stu ...

Ultrasensitive ctDNA detection with NeXT Personal shows 81% sensitivity in early-stage lung adenocarcinoma, improving ...

Researchers identify distinct molecular and immune profiles that impact the prognosis of patients with metastatic pancreatic ductal adenocarcinoma.

By staying abreast of signs and risk factors, such as persistent indigestion, unexplained weight loss, or discomfort in the ...

Telisotuzumab adizutecan is under clinical development by AbbVie and currently in Phase I for Renal Cell Carcinoma.